https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
CT03785730 . Ethics Reference No 91569118.8.0000.5597. Trial Sponsor Universidade Ibirapuera. The Trial was prospectively registered. The NRCC could be an option to manage carious lesions on proximal surfaces of primary teeth, and the approach could be well accepted by the children and parents/legal guardians. Trial registration Clinicaltrials.gov registration NCT03785730, Registered on December 18th 2018, first participant recruited 30/04/2019, https//clinicaltrials.gov/ct2/show/NCT03785730 . Ethics Reference No 91569
Мне нравится
Комментарий
Перепост
